Search

Your search keyword '"Shields, Adrian"' showing total 227 results

Search Constraints

Start Over You searched for: Author "Shields, Adrian" Remove constraint Author: "Shields, Adrian"
227 results on '"Shields, Adrian"'

Search Results

2. Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients

4. Saliva antiviral antibody levels are detectable but correlate poorly with serum antibody levels following SARS-CoV-2 infection and/or vaccination

15. SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study

18. Safety and 30-day outcomes of tracheostomy for COVID-19: a prospective observational cohort study

19. Sensitive Detection of SARS-CoV-2-Specific Antibodies in Dried Blood Spot Samples

20. Changes in immunoglobulin levels during clozapine treatment in schizophrenia

24. SARS-CoV-2 infection is associated with anti-desmoglein 2 autoantibody detection

26. Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens

28. Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens

29. Dose reductions in immunoglobulin replacement are associated with increased antibiotic usage in patients with antibody deficiency.

30. Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience

31. Vitamin D status: a U-shaped relationship for SARS-CoV-2 seropositivity in UK healthcare workers

32. Correlation Between Postvaccination Anti-Spike Antibody Titers and Protection Against Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Population-Based Longitudinal Study

33. SARS-CoV-2 infection is associated with anti-desmoglein 2 autoantibody detection

34. SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement Activation

35. Evolution of long-term vaccine induced and hybrid immunity in healthcare workers after different COVID-19 vaccination regimens: a longitudinal observational cohort study

37. SARS‐CoV‐2‐specific IgG1/IgG3 but not IgM in children with Pediatric Inflammatory Multi‐System Syndrome

38. Changes in immunoglobulin levels during clozapine treatment in schizophrenia

39. Increased seroprevalence and improved antibody responses following third primary SARS-CoV-2 immunisation: an update from the COV-AD study

40. Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals

41. Treatment of chronic or relapsing COVID-19 in immunodeficiency

42. Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK

43. SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings From The COV-AD Study

44. T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study

45. Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose

46. Evolution of Long-Term Hybrid Immunity in Healthcare Workers after Different Covid-19 Vaccination Regimens: A Longitudinal Observational Cohort Study

47. COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience

48. SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study

49. In vitro, classical complement activation differs by disease severity and between SARS-CoV-2 antigens

50. Vaccine Efficacy after Rituximab Exposure: First Interim Analysis of Virtue Project on Behalf of West Midlands Research Consortium, UK

Catalog

Books, media, physical & digital resources